Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
Johannes HolfeldFelix NaegeleLeo PölzlClemens EnglerMichael GraberJakob HirschSophia SchmidtAgnes MayrFelix TrogerMathias PammingerMarkus TheurlMichael SchreinlechnerNikolay SapplerElfriede Ruttmann-UlmerWolfgang SchadenJohn P CookeHanno UlmerAxel BauerCan Gollmann-TepeköylüMichael GrimmPublished in: European heart journal (2024)
In conclusion, the CAST-HF trial indicates that direct cardiac SWT, in addition to coronary bypass surgery improves LVEF and physical capacity in patients with ischaemic heart failure.
Keyphrases
- heart failure
- left ventricular
- minimally invasive
- acute heart failure
- coronary artery bypass
- coronary artery disease
- coronary artery
- aortic stenosis
- study protocol
- phase iii
- clinical trial
- phase ii
- cardiac resynchronization therapy
- surgical site infection
- physical activity
- mental health
- percutaneous coronary intervention
- atrial fibrillation
- randomized controlled trial
- mesenchymal stem cells
- stem cells
- acute coronary syndrome
- cell therapy